Therapy of Delta Hepatitis

Por Yurdaydin, Cihan, Idilman, Ramazan
Publicado no Cold Spring Harb Perspect Med (2015)

Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients

Por Marcellin, Patrick, Bonino, Ferruccio, Yurdaydin, Cihan, Hadziyannis, Stephanos, Moucari, Rami, Kapprell, Hans-Peter, Rothe, Vivien, Popescu, Matei, Brunetto, Maurizia R.
Publicado em 2012

Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

Por Toy Mehlika, Önder Fatih, Wörmann Tanja, Bozdayi A Mithat, Schalm Solko W, Borsboom Gerard J, van Rosmalen Joost, Richardus Jan, Yurdaydin Cihan
Publicado em 2011-12-01

Emergence of a Novel Mutation in the FLLA Region of Hepatitis B Virus during Lamivudine Therapy

Por Pai, S. Balakrishna, Bozdayi, A. Mithat, Pai, Rekha B., Beker, Tolunay, Sarioglu, Mustafa, Turkyilmaz, Ahmet R., Grier, Jason, Yurdaydin, Cihan, Schinazi, Raymond F.
Publicado em 2005

Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review

Por Toy, Mehlika, Önder, Fatih Oguz, Wörmann, Tanja, Bozdayi, A Mithat, Schalm, Solko W, Borsboom, Gerard J, van Rosmalen, Joost, Richardus, Jan Hendrik, Yurdaydin, Cihan
Publicado em 2011

The cost-effectiveness of treating chronic hepatitis B patients in a median endemic and middle income country

Por Toy, Mehlika, Onder, Fatih Oguz, Idilman, Ramazan, Kabacam, Gokhan, Richardus, Jan Hendrik, Bozdayi, Mithat, Akdogan, Meral, Kuloglu, Zarife, Kansu, Aydan, Schalm, Solko, Yurdaydin, Cihan
Publicado em 2012

Pegylated interferon-alpha plus taurine in treatment of rat liver fibrosis

Por Tasci, Ilker, Mas, Mehmet Refik, Vural, Sevil Atalay, Deveci, Salih, Comert, Bilgin, Alcigir, Gunay, Mas, Nuket, Akay, Cemal, Bozdayi, Mithat, Yurdaydin, Cihan, Bozkaya, Hakan, Uzunalimoglu, Ozden, Isik, Ahmet Turan, Said, Harun M
Publicado no World J Gastroenterol (2007)

Using Chimeric Mice with Humanized Livers to Predict Human Drug Metabolism and a Drug-Drug Interaction

Por Nishimura, Toshiko, Hu, Yajing, Wu, Manhong, Pham, Edward, Suemizu, Hiroshi, Elazar, Menashe, Liu, Michael, Idilman, Ramazan, Yurdaydin, Cihan, Angus, Peter, Stedman, Catherine, Murphy, Brian, Glenn, Jeffrey, Nakamura, Masato, Nomura, Tatsuji, Chen, Yuan, Zheng, Ming, Fitch, William L., Peltz, Gary
Publicado em 2013

Oral prenylation inhibition with lonafarnib in chronic hepatitis D infection: a proof-of-concept randomised, double-blind, placebo-controlled phase 2A trial

Por Koh, Christopher, Canini, Laetitia, Dahari, Harel, Zhao, Xiongce, Uprichard, Susan L, Haynes-Williams, Vanessa, Winters, Mark A, Subramanya, Gitanjali, Cooper, Stewart L, Pinto, Peter, Wolff, Erin F, Bishop, Rachel, Han, Ma Ai Thanda, Cotler, Scott J, Kleiner, David E, Keskin, Onur, Idilman, Ramazan, Yurdaydin, Cihan, Glenn, Jeffrey S, Heller, Theo
Publicado no Lancet Infect Dis (2015)

Anti-HDV IgM as a Marker of Disease Activity in Hepatitis Delta

Por Wranke, Anika, Heidrich, Benjamin, Ernst, Stefanie, Calle Serrano, Beatriz, Caruntu, Florin Alexandru, Curescu, Manuela Gabriela, Yalcin, Kendal, Gürel, Selim, Zeuzem, Stefan, Erhardt, Andreas, Lüth, Stefan, Papatheodoridis, George V., Bremer, Birgit, Stift, Judith, Grabowski, Jan, Kirschner, Janina, Port, Kerstin, Cornberg, Markus, Falk, Christine S., Dienes, Hans-Peter, Hardtke, Svenja, Manns, Michael P., Yurdaydin, Cihan, Wedemeyer, Heiner
Publicado em 2014